COMMUNIQUÉS West-GlobeNewswire

MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
12/02/2025
NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, [...]
SAFE GROUP - CHIFFRE D’AFFAIRES 2024
12/02/2025
CHIFFRE D’AFFAIRES 2024 Fleurieux-sur-l’Arbresle - France - le 12 février 2025 à 18h30. Safe Group publie son chiffre d’affaires annuel consolidé réalisé sur l’exercice 2024. En K€ 2024 (1) 2023 (2) Variation en % [...]
EssilorLuxottica: Q4/FY 2024 Results - Sound sales growth and margin expansion in 2024. Smartglasses as a new driver, Nuance off to a promising start
12/02/2025
Sound sales growth and margin expansion in 2024 Smartglasses as a new driver, Nuance off to a promising start Group revenue at constant exchange rates 1 +9.2% in Q4 and +6.0% in the FY North America accelerating in Q4, [...]
EssilorLuxottica: Résultats T4 et annuels 2024 - Solide croissance du chiffre d’affaires et augmentation de la marge en 2024. Un nouveau vecteur de croissance : les lunettes connectées, débuts prometteurs de Nuance Audio
12/02/2025
Solide croissance du chiffre d’affaires et augmentation de la marge en 2024 Un nouveau vecteur de croissance : les lunettes connectées, débuts prometteurs de Nuance Audio Hausse de +9,2 % du chiffre d'affaires du Groupe [...]
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
12/02/2025
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the [...]
Legend Senior Living® Expands with New Residence in King of Prussia
12/02/2025
PHILADELPHIA, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior living provider headquartered in Wichita, KS, is partnering in the new ownership and will operate Anthology Living in King of [...]
Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025
12/02/2025
ALK ( ALKB:DC / OMX: ALK B / AKBLF ) will publish its annual report for 2024 in the morning on Wednesday, 19 February 2025. Later on the same day, the company will host a presentation for investors and analysts at 1:30 [...]
Genmab Publishes 2024 Annual Report
12/02/2025
Company Announcement COPENHAGEN, Denmark; February 12, 2025 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a summary of business progress in 2024, financial [...]
Tanke Biosciences Corp Announces Appointment of Vincent Renz as Chief Executive Officer and Member of the Board of Directors
12/02/2025
Las Vegas, NV, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that Vincent Renz has been appointed Chief Executive Officer and will join the Board of Directors, [...]
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
12/02/2025
Late-breaking oral presentation features echocardiographic data analysis showing favorable impact of AVIM therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of heart [...]
Board member Roland Norberg requests to resign from the Board
12/02/2025
Aino Health AB's board member Roland Norberg has today, 12 February 2025, requested to resign from the company's board. The reason for the resignation is that the company that nominated Roland Norberg, Norberg & [...]
Pedal for Progress with Jack Ride: Canadians Ride for Youth Mental Health
12/02/2025
Join tens of thousands of Jack.org supporters to raise hope and funds together CAPTION: Hundreds come together for Jack Ride to support programs equipping youth with vital mental health education TORONTO, Feb. 12, 2025 [...]
Pédalons pour la cause : la Jack Ride mobilise le pays pour la santé mentale des jeunes
12/02/2025
Rejoignez les milliers de Canadien.ne.s qui se mobilisent pour offrir espoir et soutien à la jeunesse LÉGENDE : Des centaines de participant.e.s qui unissent leurs efforts lors de la Jack Ride pour financer des [...]
ZymoChem Achieves Commercial-Scale Production of Key Biopolymer Ingredient For BAYSE BioSAP
12/02/2025
Biomanufacturing Leader Scales Up Technology to Drive Sustainability in Chemicals Industry SAN LEANDRO, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZymoChem , the biotech company creating sustainable materials for [...]
Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
12/02/2025
New Patent expands patent estate covering Adial’s unique molecular genetic approach to diagnosing and potentially treating alcohol and drug dependence GLEN ALLEN, Va., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Adial [...]
New York Blood Center Enterprises Researchers Identify New Immune Response Mechanisms in Sickle Cell Disease
12/02/2025
NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- New York City Blood Center Enterprises (“NYBCe”) today announced that their researchers have uncovered a critical mechanism that could potentially transform treatment [...]
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
12/02/2025
Rebranding Invizyne Technologies, Inc to eXoZymes Inc. Changing NASDAQ ticker from IZTC to EXOZ Introducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE [...]
Bluejay Therapeutics Appoints Mary Cromwell as Senior Vice President and Head of Technical Operations
12/02/2025
REDWOOD CITY, Calif., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics , a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver [...]
MAPS Announces Search for New Executive Director as it Doubles Down on Advocacy and Movement Building
12/02/2025
MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion, and major donor [...]

Pages